Table 4.
In vitro anti-proliferative activities of selected potent thio-barbituric acid derivatives (from Table 1) on pancreatic, breast, and colon cancer cells (48 h treatment).a
Compounds | Cancer cells (IC50, μM) | |||
---|---|---|---|---|
| ||||
Pancreatic cancer | Breast Cancer | Colon cancer | ||
|
||||
Panc-1 | MDA-MB-231 | MCF-7 | HCT-116 | |
|
||||
2a | 24.4 ± 3.7 | 16.5 ± 1.8 | 27.9 ± 4.2 | 20.1 ± 3.5 |
2b | 19.1 ± 2.9 | 7.6 ± 2.1 | 16.2 ± 3.2 | 7.7 ± 0.6 |
2d | 7.9 ± 1.7 | 4.5 ± 0.9 | 4.4 ± 1.1 | 3.6 ± 1.4 |
8b | 8.3 ± 3.1 | 8.3 ± 2.7 | 16.5 ± 1.7 | 2.4 ± 0.9 |
8c | 21.0 ± 3.9 | 8.6 ± 1.3 | 23.5 ± 2.3 | 18.2 ± 1.8 |
8e | 20.5 ± 2.5 | 8.5 ± 2.9 | 24.0 ± 0.5 | 8.3 ± 3.2 |
Values are the mean of triplicates of at least two independent experiments. Non-linear graphs using Prism software were used to determine Mean ± SD values.